About Ibandronate Sodium
Our clients can avail from us highly effective Ibandronate Sodium that inhibits osteoclast-mediated bone resorption. It is freely soluble in water and practically insoluble in organic solvents. The chemical name for ibandronate sodium is 3-(N-methyl-N-pentyl) amino-1-hydroxypropane-1,1diphosphonic acid, monosodium salt, monohydrate with the molecular formula C9H22NO7P2NaH2O and a molecular weight of 359.24. Our clients can avail this Ibandronate Sodium in various packaging options to meet their diverse needs.
Features:
-
Accurate composition
-
Long shelf life
-
No side effect
-
Effectiveness
| Chemical Name | ibandronate sodium; [1-Hydroxy-3-(methylpentylamino)-propylidene]bisphosphonic acid sodium salt |
| Molecular Formulae | C9H22O7NP2Na |
| Mol. Wt. | 341.21 |
| CAS No | 138926-19-9 |
| Therapeutic Category
| Osteoporosis |
Effective Osteoporosis ManagementIbandronate Sodium tablets provide targeted prevention and treatment for osteoporosis in postmenopausal women. By strengthening bones and reducing fracture risks, these tablets play a crucial role in maintaining bone health and mobility. Consistent usage as per medical guidance ensures best outcomes.
Proper Usage and Dosage InstructionsFor maximum efficacy, take one 150 mg tablet with a full glass of water at least 60 minutes before ingesting food, beverages, or other medications. Remain upright for at least one hour post-dose to ensure proper absorption and minimize gastrointestinal side effects.
Safe Handling and StorageTo preserve tablet quality, store blister packs in a cool, dry location, away from direct sunlight and moisture. Follow all packaging and storage guidelines to maintain medication efficacy and prevent deterioration.
FAQs of Ibandronate Sodium:
Q: How should Ibandronate Sodium tablets be taken for optimal effectiveness?
A: Take one tablet orally with a full glass of plain water at least 60 minutes before consuming any food, beverages, or other medications. Remain upright for at least one hour after taking the dose to ensure proper absorption.
Q: What is the main benefit of using Ibandronate Sodium for postmenopausal women?
A: Ibandronate Sodium helps prevent and treat osteoporosis in postmenopausal women by increasing bone density and reducing the risk of osteoporosis-related fractures.
Q: When is the recommended time to take Ibandronate Sodium?
A: It is best taken first thing in the morning, on an empty stomach, at least 60 minutes before any food, drink, or other oral medication, once a month or as prescribed by your physician.
Q: Where should Ibandronate Sodium tablets be stored?
A: Store the tablets in their original blister packs in a cool, dry place, away from sunlight and moisture, to maintain their quality and effectiveness.
Q: What precautions should I follow during the dosage process?
A: After taking the tablet, do not lie down or recline for at least 60 minutes. This helps prevent irritation of the esophagus and ensures effective absorption of the medication.
Q: Who is suitable for Ibandronate Sodium therapy?
A: These tablets are recommended for adult postmenopausal women diagnosed with osteoporosis. They should be used strictly as directed by a healthcare professional.
Q: What is included in the packaging of Ibandronate Sodium?
A: Each box contains 10 blister packs, each holding one 150 mg tablet. Additional packaging details can be specified by the manufacturer, exporter, or supplier as required.